Return To Blog

COVID-19 ELIMINATING ONSITE MONITORING VISITS IN CLINICAL STUDIES

MANA RBM HAS THE IMMEDIATE REMOTE RISKED BASED MONITORING SOLUTION

By Penny Manasco - March 9, 2020

Our network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are your main oversight approach, the solution to this problem is available now. 

MANA RBM provides remote risk-based monitoring (RBM) customized to your protocol.  We deliver our solution, customized to the areas of greatest concern, specific to your study.  Subject review can begin within days.

We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV.  Within days, we started remote subject review.  Within 2 months, we identified critical errors that SDV did not find. Here is the link to the head to head comparison:  http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv

To protect your subjects, protect your study, and protect your asset, contact us immediately to get started.  Contact Penelope Manasco, M.D  at pmanasco@manarbm.com or 919-556-9456.